Search by Drug Name or NDC

    NDC 53002-1700-09 PANTOPRAZOLE SODIUM 20 mg/1 Details

    PANTOPRAZOLE SODIUM 20 mg/1

    PANTOPRAZOLE SODIUM is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is PANTOPRAZOLE SODIUM.

    Product Information

    NDC 53002-1700
    Product ID 53002-1700_91c26d75-ee3e-4ee6-9cae-abfc89ad71ac
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name PANTOPRAZOLE SODIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name PANTOPRAZOLE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name PANTOPRAZOLE SODIUM
    Labeler Name RPK Pharmaceuticals, Inc.
    Pharmaceutical Class Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202882
    Listing Certified Through 2024-12-31

    Package

    NDC 53002-1700-09 (53002170009)

    NDC Package Code 53002-1700-9
    Billing NDC 53002170009
    Package 3 TABLET, DELAYED RELEASE in 1 BOTTLE (53002-1700-9)
    Marketing Start Date 2023-01-01
    NDC Exclude Flag N
    Pricing Information N/A